Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

3,668 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
Phase II Trial of Cabozantinib in Recurrent/Metastatic Endometrial Cancer: A Study of the Princess Margaret, Chicago, and California Consortia (NCI9322/PHL86).
Dhani NC, Hirte HW, Wang L, Burnier JV, Jain A, Butler MO, Welch S, Fleming GF, Hurteau J, Matsuo K, Matei D, Jimenez W, Johnston C, Cristea M, Tonkin K, Ghatage P, Lheureux S, Mehta A, Quintos J, Tan Q, Kamel-Reid S, Ludkovski O, Tsao MS, Wright JJ, Oza AM. Dhani NC, et al. Among authors: matsuo k. Clin Cancer Res. 2020 Jun 1;26(11):2477-2486. doi: 10.1158/1078-0432.CCR-19-2576. Epub 2020 Jan 28. Clin Cancer Res. 2020. PMID: 31992589 Free PMC article. Clinical Trial.
Efficacy of Modified Dose-dense Paclitaxel in Recurrent Cervical Cancer.
Machida H, Moeini A, Ciccone MA, Mostofizadeh S, Takiuchi T, Brunette LL, Roman LD, Matsuo K. Machida H, et al. Among authors: matsuo k. Am J Clin Oncol. 2018 Sep;41(9):851-860. doi: 10.1097/COC.0000000000000394. Am J Clin Oncol. 2018. PMID: 28763329 Free PMC article.
Immune Activation in Patients with Locally Advanced Cervical Cancer Treated with Ipilimumab Following Definitive Chemoradiation (GOG-9929).
Da Silva DM, Enserro DM, Mayadev JS, Skeate JG, Matsuo K, Pham HQ, Lankes HA, Moxley KM, Ghamande SA, Lin YG, Schilder RJ, Birrer MJ, Kast WM. Da Silva DM, et al. Among authors: matsuo k. Clin Cancer Res. 2020 Nov 1;26(21):5621-5630. doi: 10.1158/1078-0432.CCR-20-0776. Epub 2020 Aug 18. Clin Cancer Res. 2020. PMID: 32816895 Free PMC article.
Multicenter phase II trial of combination chemotherapy with weekly paclitaxel and 5-fluorouracil for the treatment of advanced or recurrent gastric carcinoma.
Ninomiya M, Kondo K, Matsuo K, Hirabayashi N, Kojima H, Kobayashi M, Kawamura S, Ando T, Musha N, Konno H, Nagata N, Usuki H, Miyashita Y, Oba K, Morita S, Sakamoto J; Japanese South West Oncology Group (JASWOG). Ninomiya M, et al. Among authors: matsuo k. J Chemother. 2007 Aug;19(4):444-50. doi: 10.1179/joc.2007.19.4.444. J Chemother. 2007. PMID: 17855190 Clinical Trial.
Targeting SRC in mucinous ovarian carcinoma.
Matsuo K, Nishimura M, Bottsford-Miller JN, Huang J, Komurov K, Armaiz-Pena GN, Shahzad MM, Stone RL, Roh JW, Sanguino AM, Lu C, Im DD, Rosenshien NB, Sakakibara A, Nagano T, Yamasaki M, Enomoto T, Kimura T, Ram PT, Schmeler KM, Gallick GE, Wong KK, Frumovitz M, Sood AK. Matsuo K, et al. Clin Cancer Res. 2011 Aug 15;17(16):5367-78. doi: 10.1158/1078-0432.CCR-10-3176. Epub 2011 Jul 7. Clin Cancer Res. 2011. PMID: 21737505 Free PMC article.
Patient-reported symptoms and survival in ovarian cancer.
Matsuo K, Ahn EH, Prather CP, Eno ML, Im DD, Rosenshein NB. Matsuo K, et al. Int J Gynecol Cancer. 2011 Dec;21(9):1555-65. doi: 10.1097/IGC.0b013e3182259c7f. Int J Gynecol Cancer. 2011. PMID: 21912266
3,668 results